Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity

Figure 1

Reverse transcription-polymerase chain reaction analysis showing upregulation of clusterin in MCF-7 tumor cells after treatment with dexamethasone (a), chemotherapeutic agent after 1 day of incubation (b), and tamoxifen (c). C, basal expression; D, doxorubicin; MW, molecular weight; P, paclitaxel.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us